Reactive astrocytes and microglia in Alzheimer's disease surround amyloid plaques and secrete proinflammatory cytokines that affect neuronal function. Relationship between cytokine signaling and amyloid-␤ peptide (A␤) accumulation is poorly understood. Thus, we generated a novel Swedish ␤-amyloid precursor protein mutant (APP) transgenic mouse in which the interferon (IFN)-␥ receptor type I was knocked out (APP/GRKO). IFN-␥ signaling loss in the APP/GRKO mice reduced gliosis and amyloid plaques at 14 months of age. Aggregated A␤ induced IFN-␥ production from co-culture of astrocytes and microglia, and IFN-␥ elicited tumor necrosis factor (TNF)-␣ secretion in wild type (WT) but not GRKO microglia co-cultured with astrocytes. Both IFN-␥ and TNF-␣ enhanced A␤ production from APP-expressing astrocytes and cortical neurons. TNF-␣ directly stimulated ␤-site APP-cleaving enzyme (BACE1) expression and enhanced ␤-processing of APP in astrocytes. The numbers of reactive astrocytes expressing BACE1 were increased in APP compared with APP/GRKO mice in both cortex and hippocampus. IFN-␥ and TNF-␣ activation of WT microglia suppressed A␤ degradation, whereas GRKO microglia had no changes. These results support the idea that glial IFN-␥ and TNF-␣ enhance A␤ deposition through BACE1 expression and suppression of A␤ clearance. Taken together, these observations suggest that proinflammatory cytokines are directly linked to Alzheimer's disease pathogenesis. Accumulating evidence supports the idea that neuroinflammation plays a significant role in the neuropathogenesis of Alzheimer's disease (AD).
Tg2576 mice deficient for CD40 ligand show a marked reduction of A␤ deposition, micro-and astrogliosis, and APP ␤-processing. 20 Thus, proinflammatory factors can play roles in AD pathogenesis.
IFN-␥, a regulatory cytokine for mononuclear phagocyte (monocyte, macrophage, dendritic cell, and microglial cell) activation and inflammation, is produced and secreted by activated T cells and natural killer cells. 21 It can also be made, to a lesser degree, by astrocytes, macrophages, and microglia. 22, 23 The potent and diverse actions of this cytokine may lead to adverse consequences for the central nervous system. For example, IFN-␥, IFN-inducible Fas, and caspase-1 are up-regulated in trisomy 16 mice, a neurodegenerative animal model of Down syndrome. 24 Higher levels of IFN-␥ and IL-2 are present in AD brains when compared with agematched controls. 25 Reduced glial inflammation in response to experimental autoimmune encephalomyelitis was previously demonstrated in IFN-␥-deficient mice. 26 However, despite these observations, the effect of IFN-␥ on AD progression is poorly understood. Thus, to better define the role played by IFN-␥ in disease, we generated APP mice in which the IFN-␥ receptor type 1 (GR) gene was knocked out (GRKO). 27 In the present study, APP/ GRKO mice were used to investigate the role of glial inflammation in amyloid deposition and clearance. We now demonstrate that IFN-␥ and TNF-␣ enhance A␤ deposition through BACE1 expression and lead to changes in A␤ clearance. These data, taken together, support the notion that proinflammatory cytokines affect the pathogenesis of AD.
Materials and Methods

APP/GRKO Mice
Tg2576 mice expressing the Swedish mutation of human APP 695 were obtained from Drs. G. Carlson and K. HsiaoAshe through the Mayo Medical Venture.
11 Tg2576 mice were backcrossed to 129S1/Sv four times, followed by crossing with GRKO mice (strain 129-Ifngr1 tm1Ag t/J; Jackson Laboratory, Bar Harbor, ME) in a 129S1/Sv background to generate APP/GR ϩ/Ϫ mice. The APP/GR ϩ/Ϫ males were intercrossed to GR ϩ/Ϫ females to generate APP/GR ϩ/ϩ (APP) and APP/GR Ϫ/Ϫ (APP/GRKO) littermates for study comparisons. Animals used for this study were APP (APP transgene-positive and GR wild type, 14 months; two males and three females), APP/GRKO (APP transgene-positive and GRKO, 14 months; one males and four females), GRKO (APP transgene-negative and GRKO, 14 months; two males and three females), and wild-type (WT, APP transgene-negative, and GR wild type, 14 months; two males and three females) mice. The APP, APP/GRKO, GRKO, and WT mice are littermates.
Genotyping Protocol
DNA samples were prepared from cut tail tips (Ͻ1.0 cm) of individual pups, and genomic DNA was extracted using the Easy DNA kit (Invitrogen, Carlsbad, CA). Polymerase chain reaction (PCR) was performed as described previously to identify APP transgene-positive mice. 28 The GR gene targeting was confirmed by PCR of genomic DNA with four primers: oIMR013, oIMR014, oIMR0587, and oIMR0588 (primer sequence and genotyping protocol posted on http://jaxmice.jax.org).
Protein Extraction and Enzyme-Linked Immunosorbent Assay (ELISA)
The animals were perfused with ice-cold normal saline, and brains were rapidly removed and bisected sagittally. A piece of frontal cortex was dissected and frozen for biochemical analysis (protein extraction, immunoblotting, and ELISA). The remainder of the brains were prepared for histological tests (frozen or paraffin-embedded) of the two hemibrains. For immunoblotting and cytokine ELISA tests, brain tissues were homogenized in solubilization buffer [50 mmol/L Tris-Cl, pH 7.5, 100 mmol/L NaCl, 2 mmol/L ethylenediaminetetraacetic acid-sodium, 1% Triton X-100, and protease inhibitor cocktails (Roche Applied Science, Indianapolis, IN)] and centrifuged at 100,000 ϫ g for 1 hour at 4°C. The protein concentration of the supernatant was quantified by BCA (Pierce, Rockford, IL) and subjected to immunoblotting. For total A␤ ELISA, brain tissues were homogenized in 5 mol/L-guanidine isothiocyanate to prepare a protein extract 29 and subjected to A␤40 and A␤42 ELISA (Biosource International, Camarillo, CA).
Immunohistochemistry
Animals were euthanized with isoflurane and perfused transcardially with 25 ml of normal (0.9%) saline as described. 15, 30 The brains were rapidly removed, and the frontal cortex was dissected and frozen until biochemical analysis. The brain region including hippocampus was immersed in freshly depolymerized 4% paraformaldehyde for 48 hours and bisected sagittally. The left hemispheres were cryoprotected by successive 24-hour immersions in 10, 20, and 30% sucrose in Sorenson's phosphate buffer immediately before sectioning. Fixed, cryoprotected brains were frozen and sectioned in the horizontal plane at 10 m using a Cryostat (Leica Microsystems Inc., Bannockburn, IL), with sections collected serially. The right hemispheres were embedded in paraffin and sectioned at a thickness of 5 m. Immunohistochemistry was performed using specific antibodies to identify cellular and molecular markers for BACE1 (rabbit polyclonal antibody; EMD Biosciences, San Diego, CA), CD11c (eBioscience, San Diego, CA), ionized calciumbinding adaptor molecule-1 (IBA1, rabbit polyclonal antibody; kindly provided by Dr. S. Kohsaka), 31 MHC class II (BD Biosciences, Rockville, MD), CD45 (Serotec, Raleigh, NC), and phosphotyrosine (Sigma, St. Louis, MO) antibodies as described. 15 Brain sections were additionally stained with thioflavin-S (Sigma) to localize deposits of amyloid in a ␤-sheet configuration. Two regions were examined quantitatively using a stereological system: the hippocampus and the cortex. On the other hand, paraffin-embedded brains were stained for A␤ (rabbit polyclonal antibody, Invitrogen) or glial fibrillary acidic protein (GFAP, rabbit polyclonal antibody; DAKO, Carpinteria, CA). Systematic uniform random sets of sections with 300-m spacing were used for staining. All immunohistochemistry was visualized using avidin-biotin-horseradish peroxidase with 3,3Ј-diaminobenzidine for color development (Vector Laboratories, Burlingame, CA). Envision Plus kit (DAKO) was used instead of avidinbiotin-horseradish peroxidase for A␤ staining. Immunofluorescence for BACE1 and GFAP was performed using anti-BACE1 rabbit polyclonal antibody (EMD Biosciences), anti-GFAP (mouse monoclonal antibody, mAb; Sigma), Alexa 594-conjugated anti-rabbit, and Alexa 488-conjugated anti-mouse secondary antibodies (Invitrogen).
Confocal Microscopic Imaging
Thirty m frozen sections of APP or APP/GRKO cortical regions were permeabilized and blocked with 0.5% Triton X-100 and 5% goat serum in phosphate-buffered saline (PBS) for 20 minutes, followed by double staining for BACE1 (1:500 dilution) and NeuN (mouse mAb, 1:200 dilution; Chemicon International, Temecula, CA) or GFAP (mouse mAb, 1:200 dilution; Sigma). After washing with PBS/0.1% Triton X, the sections were incubated with Alexa 568-conjugated anti-rabbit and Alexa 647-conjugated anti-mouse secondary antibodies (Invitrogen) and counterstained with a derivative of 10 mol/L Congo red (E,E)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy) styrylbenzene (FSB; Dojindo, Gaithersburg, MD), which specifically binds to the ␤-sheet conformation of A␤ plaques with an excitation/emission wavelength of 390/ 511 nm. Of note, there is no overlap between Alexa 568 or Alexa 647 excitation/emission wavelengths. 32, 33 After mounting the sections on slides with Vectashield (Vector Laboratories), the confocal images of A␤ plaque regions were captured using a Nikon SweptField slit-scanning confocal microscope (Nikon Instruments, New York, NY) with a 100ϫ TIRF objective and back-illuminated chargecoupled device camera Cascade 512B (Photometrics, Tucson, AZ), with excitation at 488 (for FSB), 568 (for Alexa 568), and 647 nm (for Alexa 647) lasers. The images were pseudocolored, autocontrasted, and merged as tricolor images (see Figure 8 ).
Image Analysis
Images were captured with a digital camera (DVC-1310C; DVC Company, Austin, TX) attached to an Eclipse TE-300, Nikon microscope using C-View v1.2 software (DVC Company). 15, 34 Ten to twenty images, covering the entire cortical and hippocampal areas, were taken per each 5-or 10-m section (10 sections per brain, 300 m spacing) at ϫ200 magnification. The measured outcome of total volume occupied by TS and A␤ immunohistochemical reaction was quantified by image software (NIH Image 1.62). Immunopositive cells (BACE1, GFAP, and IBA1 staining) were counted manually. Data are reported as a percentage of the total stained area divided by the total cortical or hippocampal area or the total number of immunostained cells divided by the total cortical or hippocampal area for each animal. Two investigators in blinded manner analyzed the immunohistochemical tests.
Immunoblots
Brain lysates (30 g) were precleared with 10 l of protein G-Sepharose FF (Amersham Pharmacia, Piscataway, NJ) to remove endogenous mouse IgG and subjected to standard immunoblotting for apolipoprotein E (apoE, rabbit polyclonal antibody; Biodesign, Saco, ME), APP (6E10 mouse mAb; Signet, Dedham, MA), APP C-terminal fragments (CTF, rabbit polyclonal antibody; Calbiochem, San Diego, CA), BACE1 (rabbit polyclonal antibody), ␤-actin (mouse mAb; Sigma), HA-tag (HA-7, mouse mAb; Sigma), inducible nitric-oxide synthase (NOS-2, rabbit polyclonal antibody; Upstate Biotechnology, Lake Placid, NY), insulin-degrading enzyme (IDE, rabbit polyclonal antibody; Oncogene Science, Cambridge, MA), and neprilysin (CD10, mouse mAb; Novocastra Laboratory, Newcastle on Tyne, UK) as described. 15, 35 Alkaline phosphatase or horseradish peroxidase-conjugated secondary antibodies were used against mouse and rabbit IgG (1:2000 dilution; Vector Laboratories), and developed using NBT/BCIP solution (Roche Applied Science, Indianapolis, IN) or chemiluminescence. 15, 35 The images were digitally captured by a computer scanner at 1200 dpi, and band intensities were quantified by NIH Image 1.62 software. Data are presented as a ratio of target band intensity/␤-actin.
Tissue Culture and Recombinant Adenovirus Infection
Primary cultured mouse astrocytes and/or astrocytes-microglia were prepared from WT and GRKO newborn pups as described and plated (5 ϫ 10 4 cells/well in poly-D-lysine-coated 24-well plates) in Dulbecco's modified eagle medium supplemented with 5% fetal bovine serum, 10% heat-inactivated horse serum, and 50 g/ml penicillin/streptomycin (all from Invitrogen). On examination of astrocyte purity by immunocytochemistry (GFAP for astrocytes and Hoechst 33342 for nuclear staining), if purity was more than 90%, cells were infected with recombinant adenovirus-expressing Swedish APP mutation (APPsw: MOI ϭ 10) as described previously 35 and stimulated with murine IFN-␥ or TNF-␣ (R&D Systems, Minneapolis, MN) for 24 hours. Primary cultured mouse microglia was prepared from WT and GRKO day 0 newborn pups as described. 36 In brief, dissociated and trypsinized newborn mouse cortices were cultured as mixed glial culture in Dulbecco's modified eagle medium supplemented with heat-inactivated 10% fetal bovine serum, heat-inactivated 5% horse serum, and 50 g/ml penicillin/streptomycin (all from Invitrogen). Microglia re-leased in the tissue culture media by shaking were collected at 14 days after the plating. After confirmation of their purity to be more than 90% by immunocytochemistry (CD11b for microglia, GFAP staining for contaminated astrocytes, and Hoechst 33342 for nuclear staining), cells were used for co-culture experiments with astrocytes or stimulated with IFN-␥ for TNF-␣ and NOS-2 expression studies. Primary culture of mouse cortical neurons were prepared from WT and GRKO E16 -17 embryo and plated (1.5 ϫ 10 5 cells/well in poly-D-lysine-coated 24-well plates) in neurobasal media with 1ϫ B27 supplement and 1 mmol/L sodium pyruvate (all from Invitrogen) as described. 37 On determining that glial contamination was less than 15% by standard immunocytochemistry (GFAP staining for contaminated astrocytes, microtubules associated protein-2 for differentiated neurons, and Hoechst 33342 for nuclear staining), neurons were infected with APPsw adenovirus and stimulated with IFN-␥ or TNF-␣ as described. The cells and tissue culture media were harvested for APP, BACE1, and ␤-actin immunoblotting and A␤, IFN-␥, and TNF-␣ ELISA.
A␤ Degradation Assay
A␤ degradation was investigated using 125 I-A␤40 as described. 38 Iodinated A␤40 was prepared using IODO beads (Pierce, Rockford, IL), synthetic A␤40 peptide (amino acids 1 to 40; Biosource International, Camarillo, CA) and 125 I (Amersham Biosciences) according to the manufacture's instruction.
125 I-A␤40 was aggregated at 37°C for 3 days with agitation and used at the final concentration of 1 mol/L (200,000 cpm/ml). Primary cultured microglia from WT or GRKO neonates (5 ϫ 10 5 cells/well in 24-well plates) were incubated for 1 hour at 37°C, washed extensively, and incubated with chasing media for 120 hours. The media (secreted A␤) were collected and cells were lysed in lysis buffer (1 mol/L NaOH) for ␥-counting of intracellular A␤. Trichloroacetic acid (TCA, Sigma) was subsequently added to the media to a final concentration of 10% for polypeptide precipitation by centrifugation at 3000 ϫ g for 15 minutes at 4°C. The radioactivity of TCA-soluble (degraded A␤) and precipitable (undegraded A␤) fractions was determined by ␥-ray counter for calculating the A␤ intracellular retention, secretion, and degradation ratio as a percent total 125 I-A␤ counts.
Statistics
All data were normally distributed. In case of multiple mean comparisons, data were analyzed by analysis of variances, followed by Newman-Keuls multiple comparison tests using statistics software (Prism 4.0; GraphPad Software Inc., San Diego, CA). In case of single mean comparison, data were analyzed by Student's t-test. A P value of less than 0.05 was regarded as a significant.
Results
GRKO Reduces Both Diffuse and Compact Amyloid Plaque Deposition
Comparisons between APP/GRKO and their APP littermates were made in neuropathological examinations of A␤. APP/GRKO mice showed significantly reduced A␤ deposition as determined by A␤ immunostaining of both cortical and hippocampal diffuse plaques at 14 months of age ( Figure 1A, top) . Quantitative immunohistochemical assays showed a 57 and 65% reduction in A␤ deposition in the cortex and hippocampus, respectively, in APP/ GRKO mice ( Figure 1B) . The number of TS-positive (TS ϩ ) compact, especially large compact plaques (Ͼ160 m in diameter), were reduced in APP/GRKO mice in both the cortex and hippocampus [ Figure 1 , A (bottom) and C]. Interestingly, the number of small compact plaques (Ͻ40 m) was not altered (data not shown). Measures of total A␤40 and A␤42 by ELISA confirmed the data set ( Figure 1D ).
GRKO and Reduced Astro-and Microgliosis
Reduced A␤ deposition correlated with reduced astrocyte numbers in both the cortex and the hippocampus of APP/GRKO mice as assessed by GFAP immunostaining (Figure 2A , cortical and hippocampal region for low-and high-power magnifications). GFAP ϩ astrocytes were reduced in the cortex and the hippocampus of APP/GRKO mice by 61 and 30%, respectively, when compared with their APP littermates ( Figure 2B ). Similar results were obtained for analysis of microgliosis as performed by IBA1 staining ( Figure 2C , cortical and hippocampal region for low-and high-power magnifications). The number of IBA1 ϩ microglia was significantly reduced in APP/ GRKO mice as compared with their APP littermates ( Figure 2D ) and in GRKO mice as compared with their WT littermates (data not shown). These IBA1 ϩ microglia showed reduced or absent CD45, MHC class II, CD11c, or phosphotyrosine immunostaining in all animal groups (data not shown). These data support the notion that the GRKO phenotype elicits reductions in both astro-and microgliosis.
APP-or A␤-Degrading Enzymes Are Not Affected by GRKO
The balance between production, aggregation, and A␤ clearance determines the extent of A␤ deposition. Although A␤ deposition was reduced in APP/GRKO mice at 14 months of age, significant differences were not found in APP expression between APP and APP/GRKO mice in the cortex of both animal groups ( Figure 3A ). In addition, the cortex levels of the A␤ degradation enzymes, IDE and neprilysin, 39, 40 were equivalent in WT, APP, GRKO, and APP/GRKO mice ( Figure 3 , B and C). Because this reflects the A␤-degrading enzyme levels, the data suggested that A␤ degradation was not affected by GRKO. Neither the levels nor ratios of ␣/␤ processing were al-tered in APP/GRKO compared with APP mice as determined by immunoblotting of APP C-terminal fragments ( Figure 4A ). The expression level of apoE, which affects A␤ aggregation in brains, 41, 42 was also unchanged among the four animal groups ( Figure 4B ).
IFN-␥, TNF-␣, and A␤ Production from Astrocytes and Microglia
To understand the molecular interaction of IFN-␥ expression and A␤ deposition, we tested whether endogenous IFN-␥ and TNF-␣ were up-regulated in brain tissue of APP and APP/GRKO mice. Cytokines were not detected by ELISA, suggesting their scarcity in the brain (data not shown). We then examined whether aggregated A␤ induces IFN-␥ glial expression. Primary cultures of astrocytes and microglia, or co-cultures of astrocytes and microglia from WT or GRKO neonates were stimulated with aggregated A␤25-35 ( Figure 5A) . 43, 44 Although no basal IFN-␥ production was observed in any of the primary astrocytes or microglia cultures, significant IFN-␥ production was observed in astrocytes and microglia co-cultures after A␤ stimulation regardless of genetic background. This suggested that astrocytes and microglia interactions are necessary for IFN-␥ production. Next, we examined whether IFN-␥ stimulates glial TNF-␣ production. As shown in Figure 5B , IFN-␥ stimulated TNF-␣ production in primary cultures of microglia cells from WT but not GRKO mice, whereas lipopolysaccharide stimulated TNF-␣ production in both WT and GRKO primary microglial cultures. Moreover, IFN-␥, but not lipopolysaccharide, stimulated NOS-2 expression in WT microglia ( Figure 5B ). However, IFN-␥ failed to induce NOS-2 expression in GRKO microglia. Interestingly, lipopolysaccharide stimulation induced NOS-2 expression in GRKO microglia, suggesting an alteration in IFN-␥-specific NOS-2 induction signaling in GRKO cells. To test whether TNF-␣ production is involved in A␤ production, primary cultures of astrocytes from WT or GRKO neonates were infected with adenovirus expressing APP Swedish mutant (APPSw), 35 followed by co-culture with microglia and IFN-␥ stimulation ( Figure 5C ). The adenovirus system was used because our initial attempts to measure A␤ production from astrocytes derived from APP transgene-positive pups were not successful. TNF-␣ production was enhanced when astrocytes were co-cul- Figure 5C ). IFN-␥ strongly stimulated TNF-␣ production from WT but not from GRKO co-cultured glia. As a control, we stimulated uninfected and GFP adenovirus-infected WT astrocytes with a combination of IFN-␥ and microglia. Microglia with or without IFN-␥ stimulation increased TNF-␣ production, although the amount of TNF-␣ is lower than Figure 3 . APP-and A␤-degrading enzyme expression. A: Protein extracts from the cortex of APP/GRKO and APP mice (n ϭ 5) were subjected to immunoblotting for APP and ␤-actin using anti-A␤ (6E10) and anti-␤-actin mAbs. The APP-immunoreactive band intensity was normalized by ␤-actin band intensity. No statistical significance was observed. B: Protein extracts (30 g/lane) from the frontal cortex of four mouse groups at 14 months of age (n ϭ 5) were subjected to immunoblotting using anti-neprilysin, anti-IDE, and anti-␤-actin mAbs. C: The band intensity of neprilysin and IDE in B was normalized by the ␤-actin signal, and the average intensity ratios were presented. No statistical significance was observed by analysis of variance test. Figure 4 . ␣/␤-CTFs and apoE levels. A: Protein extracts from the cortex of APP/GRKO and APP mice (n ϭ 5) were subjected to immunoblotting for APP ␣/␤-CTFs and ␤-actin using anti-APP C-terminal antibody (CT-20, Calbiochem) and anti-␤-actin mAbs. The ␣/␤-CTF band intensity was normalized by ␤-actin band intensity. No statistical significance was observed in ␣-CTF/ ␤-actin ratio, ␤-CTF/␤-actin ratio, or ␤-CTF/␣-CTF ratio between APP and APP/GRKO mice. B: Protein extracts (30 g/lane) from the frontal cortex of four mouse groups at 14 months of age (n ϭ 5) were subjected to immunoblotting using anti-apoE and anti-␤-actin mAbs. The band intensity of apoE was normalized by the ␤-actin signal and the average intensity ratios were presented. No statistical significance was observed by analysis of variance. Figure S1 , see http://ajp.amjpathol.org). IFN-␥ stimulation alone did not increase TNF-␣ production in GFP adenovirus-infected or -uninfected astrocytes. These data support the idea that A␤ produced from APPsw-expressing astrocytes may aggregate and act as a co-stimulatory molecule to stimulate IFN-␥ or microglia-induced TNF-␣ production in astrocytes. This TNF-␣ up-regulation is correlated with a significantly increased A␤ production from co-cultured WT glia, which is further enhanced by IFN-␥ stimulation ( Figure 5D ). This is not attributable to the up-regulation of APP expression, as shown by immunoblotting for full-length APP ( Figure 5D, bottom) . Treatment of the astrocytes with a BACE inhibitor (BACE-I) completely blocked A␤ production, demonstrating its dependence on BACE enzyme activity. As a control, A␤ production from control WT or GRKO astrocytes without APPsw expression was undetectable. Most importantly, this IFN-␥-induced increase of A␤ production from cocultured glia was completely blocked by co-incubation with an anti-TNF-␣ neutralizing monoclonal antibody (TNF-␣ mAb, Figure 5D ), suggesting that TNF-␣ mediates A␤ production.
APPsw-expressing astrocytes (Supplemental
TNF-␣ Enhances Astrocyte BACE1 Expression and A␤ Production
To directly demonstrate TNF-␣-induced A␤ production from astrocytes, astrocyte primary cultures from WT neonates were infected with APPsw adenovirus and stimulated with increasing doses of TNF-␣ for 24 hours, and A␤ production was determined. TNF-␣ stimulation increased A␤40 levels in primary astrocytes in a dose-dependent manner and could be inhibited by anti-TNF-␣-neutralizing antibody ( Figure 6A ). A␤42 was similarly up-regulated on TNF-␣ stimulation (data not shown). Full-length APP expression measured after TNF-␣ stimulation was comparable among groups ( Figure 6A, bottom) . The increase in A␤ production by TNF-␣ stimulation correlates with an increase of secreted ␤-processing product of APP (sAPP␤) in the tissue culture media, supporting the idea that ␤-processing was induced by TNF-␣. It was recently reported that stimulation of astrocytes with IFN-␥ and TNF-␣ induces the expression of BACE1 in vitro and that BACE1 is up-regulated in plaque-associated GFAP ϩ astrocytes in Tg2576 mice in vivo. [45] [46] [47] Thus, we have ex- amined whether TNF-␣ stimulates BACE1 expression in astrocytes. As expected, an up-regulation of astrocyte's BACE1 expression was observed after TNF-␣ stimulation, which was blocked by an anti-TNF-␣-neutralizing antibody ( Figure 6B ).
IFN-␥ and TNF-␣ Enhance Neuronal A␤
Because A␤ is mainly produced from neurons and considering the reduction of A␤ deposition in APP/GRKO mice in vivo, it is possible that IFN-␥ and TNF-␣ also modulate neuronal A␤ production. To address this issue, differentiated primary culture of mouse cortical neurons derived from E16 WT and GRKO embryos were infected with APPsw adenovirus followed by IFN-␥ and TNF-␣ stimulation. As shown in Figure 7 , both IFN-␥ and TNF-␣ significantly increased A␤ production in WT neurons (*P Ͻ 0.01 for WT and P Ͻ 0.05 for GRKO neurons). The TNF-␣-induced A␤ production was threefold higher than the unstimulated control and was blocked by co-incubation of TNF-␣ with anti-TNF-␣-neutralizing antibody (#P Ͻ 0.05), demonstrating its cytokine specificity. TNF-␣, but not IFN-␥, increased A␤ production from GRKO neurons, demonstrating that the IFN-␥-induced stimulation of A␤ production is mediated through GR. These data demonstrate that IFN-␥ and TNF-␣ stimulate A␤ production from neurons.
BACE1 Expression in APP and APP/GRKO Mice
We examined whether BACE1 is up-regulated in aged APP or APP/GRKO mouse brain by immunohistochemistry. We observed a diffuse intense staining of BACE1 in the cortical region of APP mice but not in APP/GRKO mice ( Figure 8 , A and D). BACE1 immunoreactivity was localized to neurons surrounding A␤ plaques as observed by confocal images of brain sections triple stained with antibodies to BACE (green), NeuN (red), and A␤ plaques (Congo Red analog FSB, blue) ( Figure 8 , B and E) and partially co-localized with astrocytes (GFAP in red, BACE in green, and FSB in blue; Figure 8 , C and F). These data suggest that although BACE1 is principally expressed in neurons, activated astrocytes surrounding the A␤ plaque also express the enzyme and that the overall BACE expression is reduced in the cortical region of APP/GRKO mice as compared with APP animals. To confirm whether BACE1 is up-regulated in reactive astrocytes in APP and APP/GRKO mice in vivo, we examined the expression of BACE1 in GFAP ϩ astrocytes (Figure 9) . GFAP Ϫ cells expressing BACE1 were neurons (data not shown). Although activated astrocytes are found commonly around plaques, the number of BACE1 ϩ neurons remained constant in both APP and APP/GRKO mice ( Figure 9 , A and B and D and E). Nonetheless, a significant reduction in the number of BACE1 ϩ astrocytes was seen in APP/GRKO mice ( Figure 9 , D-F) as compared with APP littermates (Figure 9 , A-C), with 74% in the cortex and 70% in the hippocampus (Figure 9 , G and H). These observations suggest that IFN-␥ signaling affects A␤ production through microglial TNF-␣ stimulation of astrocyte BACE1 expression. . TNF-␣-stimulated astrocytes enhance A␤ production and BACE1 expression. A: Top: A␤40 ELISA of tissue culture media collected from astrocyte primary cultures isolated from WT or GRKO neonates 24 hours after APPsw adenovirus infection and TNF-␣ (1, 10, and 100 ng/ml) stimulation or APPsw adenovirus infection and 10 ng/ml TNF-␣ plus 10 g/ml ␣-TNF-␣ mAb stimulation. Bottom: The same set of tissue culture media (100 l) was subjected to immunoprecipitation with 20 g of 6E10 mAb (against A␤1-17 sequence) overnight at 4°C to deplete A␤ and sAPP␣. Supernatant after the immunodepletion was subjected to immunoblotting using anti-HA antibody, showing sAPP␤. Expression of full-length APP (APP) was examined by cell lysates. Expression of ␤-actin was used as a loading control. B: Cell lysates from astrocyte primary cultures isolated from WT or GRKO neonates stimulated by murine TNF-␣ (10 ng/ml) with or without anti-TNF-␣ antibody (␣-TNF-␣ mAb, 10 g/ml) for 24 hours, were subjected to immunoprecipitation with anti-BACE1 polyclonal antibody. The immunoprecipitated fraction was subjected to immunoblotting using anti-BACE1. The BACE1 band intensity was normalized against the ␤-actin level in the original cell lysate. 
IFN-␥ and TNF-␣ Suppress Microglial A␤ Degradation
Because glial cells, particularly microglia, are significantly involved in the clearance of aggregated A␤ in brain parenchyma, it is possible that cytokines modulate A␤ degradation in microglia. To study this, microglia primary cultures from WT and GRKO neonates were pulse-labeled with aggregated 125 I-A␤40, and chased for 120 hours with or without IFN-␥ and/or TNF-␣ stimulation. The basal uptake of 125 I-A␤ 1 hour after the initial incubation was ϳ70% of total input, with no difference observed between WT and GRKO microglia (Supplemental Figure S2 , see http://ajp.amjpathol.org). At the end point, 125 I-A␤ in the microglia and the tissue culture media were treated with TCA to separate degraded (TCA-soluble) and undegraded (TCA-precipitable) 125 I-A␤. As shown in Figure 10 , co-stimulation of WT microglia with IFN-␥ and TNF-␣ but not stimulation by IFN-␥ treatment or TNF-␣ treatment alone shows a significant increase of intracellular A␤ retention ( Figure 10A ). Because more than 95% of intracellular A␤ is TCA-precipitable (data not shown), this suggests that intracellular A␤ degradation is significantly reduced. Intracellular A␤ retention was not affected by cytokine stimulation in GRKO mice, suggesting that suppression is dependent on IFN-␥. This was correlated with reduced TCA-soluble A␤ secretion from IFN-␥ and TNF-␣ co-stimulated WT astrocytes ( Figure 10B ). TCA-insoluble A␤ secretion, which is a minor fraction of the overall A␤ metabolism, was unaffected by either genotype or cytokine treatment ( Figure 10C ). Taken together, these data suggest IFN-␥ and TNF-␣ reduce A␤ clearance in WT but not GRKO microglia. The data also provide an explanation for the reduced A␤ deposition observed in APP/GRKO mice.
Discussion
Our data demonstrate a unique role for IFN-␥ signaling in A␤ production and deposition in APP mice. A prominent role for IFN-␥ is supported by several observations. 1) GRKO reduces both astro-and microgliosis in both the hippocampus and the cortex of APP mice; 2) reduced gliosis is accompanied by similarly reduced A␤ deposition (diffuse and compact); 3) IFN-␥ stimulation enhances A␤ expression in glial co-cultures, which is blocked by anti-TNF-␣ neutralizing antibody; 4) TNF-␣ stimulates as- 688 Yamamoto et al AJP February 2007, Vol. 170, No. 2 trocyte A␤ production and BACE1 expression; 5) GRKO significantly reduces the BACE1 expression of reactive astrocytes in vivo; and 6) co-stimulation of IFN-␥ and TNF-␣ suppress microglial A␤ clearance. These data taken together suggest that glial activation participates in enhanced A␤ deposition through IFN-␥, TNF-␣, and BACE1 expression, and reduced A␤ clearance. Because there were no demonstrable differences in APP and APP/ GRKO mice in APP expression, ␣/␤-processing, apoE-, or A␤-degrading enzymes, it is likely that the reduced A␤ deposition is attributable to reduced A␤ production and is not through suppressed A␤ clearance by cytokines in APP/GRKO mice.
How glial inflammation leads to enhanced A␤ deposition is unknown. Treatment of APP mice with nonsteroidal anti-inflammatory drugs (NSAIDs) results in reduced glial inflammation and A␤ deposition. 48, 49 Because NSAIDs also affect ␥-secretase complex-mediated processing of APP, these studies were not conclusive in addressing the question of how glial inflammation affects A␤ deposition. Using the APP/GRKO transgenic mice, we have now specifically addressed whether suppression of glial inflammation by disruption of IFN-␥ signaling, a prototypical T-cell-mediated proinflammatory cytokine, affects A␤ deposition in vivo. We demonstrated a significant correlation between reduced A␤ plaque formation and reduced glial inflammation in APP/GRKO mice. Previously studies reported that both IFN-␥ and IL-12 are up-regulated in microglia and astrocytes in Tg2576. 16 Thus, our study suggests a significant role for IFN-␥ in the crosstalk between astrocytes and microglia during brain inflammation and in disease.
We have demonstrated that IFN-␥ affects A␤ generation through stimulating TNF-␣. TNF-␣ levels are elevated in AD serum, 50 CSF, and cortex. 51 Although there are a number of studies on the neurotoxic or neurotrophic action of TNF-␣, 1 limited information is available on its effect on APP processing. IFN-␥ and TNF-␣ induce enhanced A␤ production from not only astrocytes but also transformed neuronal cells in vitro. 52, 53 Our data suggest that this is attributable to the crosstalk of glial cells, which induces BACE1 up-regulation. This finding is supported by a report that IFN-␥ induces BACE1 expression in U373MG astrocytoma cells. 47 As an alternative mechanism, IFN-␥ and TNF-␣ can also modestly enhance ␥-secretase-mediated processing of APP in COS-7 and human embryonic kidney 293 cells. 54 Although we did not see a significant difference in the total amount of ␣-and ␤-CTF, the ␥-secretase substrates, between APP and APP/GRKO mice, this could be an additional mechanism of reduced A␤ production in APP/GRKO mice.
Studies on postmortem AD brain showed BACE1 upregulation in both mRNA and its enzyme activity. [55] [56] [57] The correlation of BACE1 up-regulation and glial inflammation has been reported in not only Tg2576 47 but also other APP transgenic mice (APP V717I). 58 Our finding of reduced BACE1 expression in APP/GRKO mice is consistent with a report on APP/CD40L-KO mice, in which they found reduced A␤ deposition, reduced gliosis, and reduced ␤-processing of APP. 20 Our study suggests that their findings are attributable to a reduced BACE1 expression mediated by the lack of CD40 signaling. Because CD40 belongs to the TNF receptor family, they share common intracellular signaling for BACE1 gene induction, such as the TNF receptor-associated factor 6 recruitment to the cytoplasmic domain, the activation of nuclear factor (NF)-B, and AP-1 transcriptional factor complex. Interestingly, five potential NF-B responsive elements were found in the proximal promoter region of human BACE1, 59 suggesting an NF-B-inducible gene expression mechanism in the BACE1 promoter regions.
Recently, Monsonego and colleagues 60 reported that another APP mouse model (J20) crossed with IFN-␥-overexpressing mice had a slightly reduced A␤ plaque burden in dentate gyrus but not in the CA1 region after immunization with A␤10-24 at 9 to 10 months of age. Their data suggest that low doses of IFN-␥ are necessary for the induction of meningoencephalitis in APP mice but that IFN-␥ effect on A␤ clearance is modest when compared with the effect of A␤ vaccination. It would be interesting to see whether higher transgene expression of IFN-␥ could alter A␤ deposition in brains of APP mice at a later time point. This is necessary to study the effect of aging in these models. Although they show that IFN-␥ enhanced A␤ uptake in microglia, we have observed a reduced A␤ degradation by IFN-␥/TNF-␣-stimulated WT microglia, but no significant difference in A␤ uptake between WT and GRKO microglia. This suggests that the mechanism of A␤ uptake and its degradation are differentially regulated by IFN-␥ in microglia.
In summary, we have demonstrated that APP/GRKO mice show reduced A␤ plaque deposition, astro-and microgliosis, and astrocyte BACE1 expression. The observations made are significant because TNF-␣ produced by IFN-␥-stimulated microglia directly correlates with increased A␤ expression from APPsw-expressing astrocytes and neurons and correlated with increased BACE1 expression. Our data suggest that IFN-␥ and TNF-␣ signaling may also affect A␤ degradation in microglia. BACE1 may play a critical role not only in the regulation of A␤ production but also in providing a novel mechanism for AD progression, in which chronic glial activation leads to the acceleration of amyloid deposition attributable to enhanced BACE1 expression. Therapeutic strategies that reduce the levels of proinflammatory cy- Figure 10 . IFN-␥-and TNF-␣-stimulated microglia reduce A␤ degradation. Primary cultured microglia from WT or GRKO neonates (50,000 cells/well) were pulse-labeled with aggregated 125 I-A␤40 (100,000 cpm/well) for 1 hour and chased with fresh tissue culture media for 120 hours in the presence or absence of IFN-␥ (10 ng/ml) and TNF-␣ (10 ng/ml). After chase, total cell lysates were collected and subjected to ␥-counting, which represents intracellular 125 I-A␤ retention. A-C: The tissue culture media were subjected to 10% TCA precipitation to separate extracellular TCA-soluble (B) and -insoluble (C) 125 I-A␤. Each fraction was presented as percent total 125 I-A␤ (a sum of each fraction for each group). *P Ͻ 0.05 versus control of the same group as determined by analysis of variance and Newman-Keuls post hoc. AJP February 2007, Vol. 170, No. 2 tokines and BACE1 could lead to attenuation of glial A␤ and could lead to novel strategies for AD treatment.
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